After all the discussion about the results I figured I'd better read beyond the highlights section
" One particular example shows the limitations even for the use of biopsies to validate the 64Cu-SAR-bisPSMA PET findings, where the first biopsy of a lymph node had a negative histopathology result for PC, which turned out positive following the complete excision of the same lymph node (Figure 3, above)"
I found that rather tasty, 64Cu finding tumours that even biopsies miss
Ann: Initial COBRA results, page-50
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.22 |
Change
-0.140(2.61%) |
Mkt cap ! $1.625B | |||
| Open | High | Low | Value | Volume |
| $5.36 | $5.50 | $5.18 | $5.452M | 1.028M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6927 | $5.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.26 | 4319 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$5.22 |
Change
-0.140 ( 1.59 %) |
||||
| Open | High | Low | Volume | ||
| $5.34 | $5.49 | $5.19 | 94951 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| CU6 (ASX) Chart |